8 terminated, 5 completed, 1 unknown. 7 Phase 3, 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 5, Completed 2 |
| Phase 2 | 5 | Completed 2, Terminated 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow bapineuzumab: new trials by email Literature Review of bapineuzumab trials Research Report on bapineuzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Retrieval of Patient Information After Discontinuation Bapineuzumab - Alzheimer's Disease | Terminated | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 169 | 2011-12-01 | 2015-09-02 | |
| A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients Bapineuzumab 0.5 mg/kg, Bapineuzumab 1.0 m/kg - Alzheimer Disease | Phase 3 | Terminated | Pfizer | 198 | 2009-12-01 | 2014-01-01 |
| A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients Bapineuzumab 0.5 mg/kg - Alzheimer Disease | Phase 3 | Terminated | Pfizer | 494 | 2009-12-01 | 2016-01-01 |
| A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease Bapineuzumab - Alzheimer's Disease | Phase 3 | Terminated | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 896 | 2009-07-01 | 2013-12-20 |
| Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab bapineuzumab - Alzheimer Disease | Phase 2 | Terminated | Pfizer | 62 | 2009-06-01 | 2017-06-01 |
| Study Evaluating Bapineuzumab In Alzheimer Disease Subjects bapineuzumab, placebo - Alzheimer Disease | Phase 2 | Completed | Pfizer | 79 | 2008-11-01 | 2013-11-15 |
| Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients bapineuzumab, placebo - Alzheimer Disease | Phase 3 | Terminated | Pfizer | 901 | 2008-06-01 | 2016-01-08 |
| Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients bapineuzumab, placebo - Alzheimer Disease | Phase 3 | Terminated | Pfizer | 1100 | 2008-01-01 | 2016-06-10 |
| Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg - Alzheimer's Disease | Phase 3 | Completed | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 1331 | 2007-12-01 | 2013-11-25 |
| Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) Bapineuzumab 0.5 mg/kg, Placebo Control, Bapineuzumab 1.0 m/kg - Alzheimer's Disease | Phase 3 | Completed | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 1121 | 2007-12-01 | 2013-11-25 |
| AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease Bapineuzumab (AAB-001) - Alzheimer's Disease | Phase 2 | Terminated | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 194 | 2006-12-01 | 2013-11-25 |
| Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease bapineuzumab - Alzheimer Disease | Phase 1 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 80 | 2006-10-01 | 2014-09-04 |
| AAB-001 in Patients With Mild to Moderate Alzheimer's Disease bapineuzumab, placebo - Alzheimer's Disease | Phase 2 | Completed | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 234 | 2005-04-01 | 2012-03-14 |
| Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease AAB-001 - Alzheimer's Disease | Phase 2 | Unknown | Pharmacology Research Institute | 2005-04-01 | 2012-05-09 |
Alzheimer Disease (14) · Plaque, Amyloid (1)
JANSSEN Alzheimer Immunotherapy Research & Development, LLC (6) · Pfizer (6) · Pharmacology Research Institute (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (11) · Japan (5) · Australia (4) · Belgium (4) · Chile (4) · Finland (4) · France (4) · Italy (4) · Netherlands (4) · New Zealand (4) · Poland (4) · Portugal (4) · Slovakia (4) · South Africa (4) · Spain (4)
PMID 24450891, PMID 25669746, PMID 26208959, PMID 26297092, PMID 27176461, PMID 27334799, PMID 28269765, PMID 29854934, PMID 29854935, PMID 30412493, PMID 22473769, PMID 26044070, PMID 30129411
2009 (1)